The Effect of Interleukin 38 on Angiogenesis in a Model of Oxygen-induced Retinopathy

Sci Rep. 2017 Jun 5;7(1):2756. doi: 10.1038/s41598-017-03079-z.

Abstract

Interleukin 38 (IL-38) is a novel identified cytokine of IL-1 family in which some members are important in inflammation and angiogenesis. However, the role of IL-38 in regulating angiogenesis is unknown. The aim of the present study is to explore the effect of IL-38 on angiogenesis. Oxygen-induced retinopathy (OIR) of C57BL/6 J mice was induced by exposure of hyperoxia (75% oxygen) from postnatal day 7 (P7) to P12 and then returned to room air. The mice were injected with IL-38. At P17, neovascular region (tufts) and avascular area of the retinas were analyzed. The data showed that administration of IL-38 in vivo inhibited retinal angiogenesis significantly. Furthermore, the addition of IL-38 to the cell cultures attenuated the proliferation, scratch wound healing and tube formation of vascular endothelial cells induced by VEGF significantly. Our findings suggest that IL-38 is an antiangiogenic cytokine in pathophysiological settings and may have therapeutic potential for angiogenesis related diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / pharmacology
  • Animals
  • Animals, Newborn
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects
  • Disease Models, Animal
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Interleukins / pharmacology*
  • Mice
  • Oxygen / adverse effects*
  • Retinal Diseases / etiology*
  • Retinal Diseases / metabolism*
  • Retinal Diseases / pathology
  • Retinal Neovascularization / etiology*
  • Retinal Neovascularization / metabolism*
  • Retinal Neovascularization / pathology

Substances

  • Angiogenesis Inhibitors
  • IL-38 protein, human
  • Interleukins
  • Oxygen